24 June 2019
SpeeDx sign collaboration agreement with GSK
SpeeDx signed a collaboration agreement with GSK to provide tests and custom test development to support antibiotic clinical trials and new product development.
“We welcome this extension of the utility and application of our tests and technology,” said Colin Denver, SpeeDx CEO.
Read the full press release.